Clariant’s Healthcare business registered its maiden presence at the CPhI India exhibition held from November 28-30, 2023 at the India Expo Mart, Greater Noida, Delhi NCR.

The company showcased it’s ‘Made in India’ products such as Vitipure Meglumine LEX and VitiPure Superior manufactured at their Bonthapally plant in the state of Telangana.

Vitipure Meglumine LEX is a low-endotoxin and microbial-load grade of Meglumine. It is used as a counterion in contrast media sector, as a buffering agent/alkalizer and solubilizer for mild acidic active pharmaceutical ingredient (APIs).

VitiPure Superior is a high-purity brand that offers purified products via a patented process to minimize residual impurities in the product which makes it colorless, odorless, with low microbial load and improves the stability of APIs.

“For Clariant, India represents a dynamically growing market for functional excipients of high purity beyond just pharmacopeia compliance with an enormous potential into parenteral applications. Indian customers prefer excipient suppliers with stringent GMP track records and local manufacturing for shorter lead times. This was also evident from the very strong business connects we established at this event,” explained Vaios Barlas, Global Head of Healthcare, at Clariant.

Clariant Healthcare is leveraging its expertise as a supplier to the pharmaceutical industry as a provider of one-stop shop solution of excipients from standard to highly purified grades for unique application-specific formulation flexibility. It also offers functional excipients to solve API delivery and bioavailability challenges.